Literature DB >> 11160856

Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells.

K Schmidt1, A Schrammel, D Koesling, B Mayer.   

Abstract

YC-1 is a direct activator of soluble guanylyl cyclase (sGC) and sensitizes the enzyme for activation by nitric oxide (NO) and CO. Because the potentiating effect of YC-1 on NO-induced cGMP formation in platelets and smooth muscle cells has been shown to be substantially higher than observed with the purified enzyme, the synergism between heme ligands and YC-1 is apparently more pronounced in intact cells than in cell-free systems. Here, we investigated the mechanisms underlying the synergistic activation of sGC by YC-1 and NO in endothelial cells. Stimulation of the cells with YC-1 enhanced cGMP accumulation up to approximately 100-fold. The maximal effect of YC-1 was more pronounced than that of the NO donor DEA/NO (approximately 20-fold increase in cGMP accumulation) and markedly diminished in the presence of L-N(G)-nitroarginine, EGTA, or oxyhemoglobin. Because YC-1 did not activate endothelial NO synthase, the pronounced effect of YC-1 on cGMP accumulation was apparently caused by a synergistic activation of sGC by YC-1 and basal NO. The effect of YC-1 was further enhanced by addition of DEA/NO, resulting in a approximately 160-fold stimulation of cGMP accumulation. Thus, YC-1 increased the NO-induced accumulation of cGMP in intact cells by approximately 8-fold. Addition of endothelial cell homogenate increased the stimulatory effect of YC-1 on NO-activated purified sGC from 1.2- to 3.7-fold. This effect was not observed with heat-denatured homogenates, suggesting that a heat-labile factor present in endothelial cells potentiates the effect of YC-1 on NO-activated sGC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160856     DOI: 10.1124/mol.59.2.220

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Properties of NO-activated guanylyl cyclases expressed in cells.

Authors:  Barry J Gibb; Victoria Wykes; John Garthwaite
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

2.  Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies.

Authors:  Johannes-Peter Stasch; Cristina Alonso-Alija; Heiner Apeler; Klaus Dembowsky; Achim Feurer; Torsten Minuth; Elisabeth Perzborn; Matthias Schramm; Alexander Straub
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 3.  New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications.

Authors:  John Garthwaite
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

4.  Probing soluble guanylate cyclase activation by CO and YC-1 using resonance Raman spectroscopy.

Authors:  Mohammed Ibrahim; Emily R Derbyshire; Michael A Marletta; Thomas G Spiro
Journal:  Biochemistry       Date:  2010-05-11       Impact factor: 3.162

5.  Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

6.  A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase.

Authors:  Nathaniel B Fernhoff; Emily R Derbyshire; Michael A Marletta
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

7.  YC-1 increases cyclo-oxygenase-2 expression through protein kinase G- and p44/42 mitogen-activated protein kinase-dependent pathways in A549 cells.

Authors:  Ming-Shyan Chang; Wen-Sen Lee; Che-Ming Teng; Horng-Mo Lee; Joen-Rong Sheu; George Hsiao; Chien-Huang Lin
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

8.  YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells.

Authors:  Xiao-Ming Liu; Kelly J Peyton; Natalia N Mendelev; Hong Wang; David A Tulis; William Durante
Journal:  Mol Pharmacol       Date:  2008-10-15       Impact factor: 4.436

Review 9.  Gas what: NO is not the only answer to sexual function.

Authors:  G Yetik-Anacak; R Sorrentino; A E Linder; N Murat
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

10.  Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide.

Authors:  Alexander Kollau; Alexandra Hofer; Michael Russwurm; Doris Koesling; Wing Ming Keung; Kurt Schmidt; Friedrich Brunner; Bernd Mayer
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.